TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. - Wikidata - awgldk - TriplyDB

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

http://www.wikidata.org/entity/Q40296306

about

The H19 non-coding RNA is essential for human tumor growth KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth Polyunsaturated fatty acid metabolism in prostate cancer Redox Control of Multidrug Resistance and Its Possible Modulation by Antioxidants Pattern Recognition Receptors in Cancer Progression and Metastasis Emerging role of Toll-like receptor 4 in hepatocellular carcinoma Transcriptional regulation of chemokine expression in ovarian cancer Drosophila at the intersection of infection, inflammation, and cancer Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II Myeloid differentiation primary response gene 88-leukotriene B4 receptor 2 cascade mediates lipopolysaccharide-potentiated invasiveness of breast cancer cells Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor inva Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial × Breast Cancer Hybrids, but Not in Parental Cells Oxidative stress, inflammation, and cancer: how are they linked?Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance.Stem-like ovarian cancer cells can serve as tumor vascular progenitors MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer.Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival.Expression-based Pathway Signature Analysis (EPSA): mining publicly available microarray data for insight into human disease.A role for NRAGE in NF-kappaB activation through the non-canonical BMP pathway.Autophagy facilitates TLR4- and TLR3-triggered migration and invasion of lung cancer cells through the promotion of TRAF6 ubiquitination.p52-Independent nuclear translocation of RelB promotes LPS-induced attachment Toll-like receptor mediated regulation of breast cancer: a case of mixed blessings.High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer.Non-invasive imaging of Toll-like receptor 5 expression using (131)I-labeled mAb in the mice bearing H22 tumors Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligation The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma.Metformin against cancer stem cells through the modulation of energy metabolism: special considerations on ovarian cancer.Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion

P2860

Q21144433-F55FCEE5-AB81-40B1-B3C3-13166D4D1C81 Q21245466-23CEDB2D-D3A4-45B3-B59F-15E1EAA5398C Q24298015-9CC31FDA-D60F-401E-8A01-76A0863D4F85 Q24618984-7E461A82-2DEA-41A2-8BF8-37B18CF277AC Q24620395-F609ED39-AD3C-4CA1-B9A1-9E333D5ACAE8 Q24629893-5C03D0E9-1BC9-41CB-AA84-466883996645 Q26765805-BCC65973-A06D-4379-93E4-EB508C338949 Q26798034-89627DE9-7FEF-4F38-8ACE-31DDD9525458 Q26824613-D76BFE19-C6ED-42F8-A0AE-D916426E25B5 Q26825361-B581DD72-6313-424D-AC05-0D5DFDF262BB Q26827570-73211BDC-2A93-466E-8A54-4D66A381D544 Q26830075-3BA2B617-D8FB-4218-A96F-5C1EE3F3F23C Q26861234-294D043C-6C05-46C8-B685-EA89A613FD47 Q27853281-103F0FDD-A971-4538-B45B-684421BB959C Q28070895-C80ACED9-B1A3-4ED5-BCDD-EBE420520D91 Q28257239-80B5D1C4-C9B9-478D-B439-EF332653731E Q28307294-25BD271C-37B5-402A-AACD-71D825A8B9E8 Q28394879-018E1C29-6EA8-4CDB-92CF-FA31E7B5F46C Q28550063-7E5FDF86-E200-468A-8815-0A1DC9F08194 Q29616835-9491F29C-3405-4ABD-BAAD-C8AB23C3EE35 Q30365844-BFC49AD1-055B-42D0-B96B-9D91B36D87C7 Q30491933-C8BF969A-89E4-4F05-8390-EFA567FC527E Q33302912-5186667B-07C9-46BE-A7C0-67CB3AB60FBA Q33312949-81440890-A1C8-41CB-81F1-BBB32889CDC0 Q33378247-6A734C70-F296-477C-A1E1-B0C67B323868 Q33526462-ABCD1C34-FDAE-4B67-A118-69DF7F454723 Q33577585-82C538CD-8AF3-4A87-B363-AA97D4488E00 Q33615344-669D9A26-54C2-4B0F-9D38-52CE659B8FA8 Q33658124-74056B91-69B7-49F5-ADDF-731BF6837610 Q33708134-96D0D73E-9B20-42FB-8CAD-43491C6A897C Q33727715-2388763F-4C6B-4F88-A58D-E6F79690C0AD Q33755300-AAC29E0E-DD2C-4FFE-BB22-0E5734FDD449 Q33762632-A14E4B79-D8F4-4071-8145-719EC199E388 Q33801246-C9E41BCF-331F-4FD5-B794-7B7D49364E24 Q33825555-91C2CC27-35AF-437C-BD36-12EAF595A867 Q33853103-088E4DC6-AB46-414B-96F0-BA87C5DD047B Q33890763-4B88E553-C607-4363-B0B7-DE34A5077098 Q33980477-BFDD0A56-189E-47E9-8C26-2077A7D25126 Q34009839-C92E12FF-5B30-440C-98B1-B724A30F0DB3 Q34036026-83BBE92A-B7F8-422A-9BD8-AE29ABDE6F33

P2860

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

http://www.wikidata.org/entity/Q40296306

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

@en

type

label

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

@en

prefLabel

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

@en

P1433

Q40296306-49E73AD6-B7FF-4FCE-B78E-75D006FBA24B

P1476

Q40296306-5B6239B4-BB75-4607-A94B-020C1A6F9883

P2093

Q40296306-03755B67-07F1-430C-80C1-EA54A9CE8482

Q40296306-443EB2A9-E1BC-4A75-A32E-0EEED2E18207

Q40296306-4BD961BE-4058-4F9B-B030-1A3E7ACFB7D7

Q40296306-52B4BF3D-3CEE-4135-BA67-B37A0590A9CE

Q40296306-6E1A52D9-87C7-4FD5-8488-6BBA65F85907

Q40296306-8255757F-A6DA-48E5-83A3-B5D5B9957EDD

Q40296306-AC6E2BCD-5CF4-47DF-85E2-BE8391870645

Q40296306-BC052841-B26C-42EB-9FC8-E8DE577F0A6F

Q40296306-EEDE0DAE-A5AA-4F76-87E6-68B55F268430

P304

Q40296306-59606D94-104F-49DE-B564-86C452F7E07F

P31

Q40296306-891DC2DF-312F-42E2-8AEE-3F8E095C42F7

P356

Q40296306-8954EA41-FB1F-413C-A736-377E04C378F5

P407

Q40296306-0CE23282-C82A-4E8A-9707-E57C6508B6B9

P433

Q40296306-8BCF91D4-B5CC-4993-A1A7-9F8DC131D3A1

P478

Q40296306-0D991BDD-A6E2-408E-9867-E41DCE8D670B

P577

Q40296306-DB1B31CF-E32A-4CCD-A5BC-72350B6B2D8C

P698

Q40296306-AE78A83E-8A6C-4EE1-9586-D38A777AE439

P921

Q40296306-5A0B0D29-29A0-44A9-B429-776E18D78C4A

Q40296306-EDD34762-3551-4FF4-9C81-8F0D78170C13

P356

0008-5472.CAN-05-3948

P1433

Cancer Research

P1476

TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer.

@en

P2093

Ayesha B Alvero

http://www.w3.org/2001/XMLSchema#string

Dan-Arin Silasi

http://www.w3.org/2001/XMLSchema#string

Gil Mor

http://www.w3.org/2001/XMLSchema#string

Irene Visintin

http://www.w3.org/2001/XMLSchema#string

Michael G Kelly

http://www.w3.org/2001/XMLSchema#string

Rui Chen

http://www.w3.org/2001/XMLSchema#string

Serena Chan

http://www.w3.org/2001/XMLSchema#string

Thomas Rutherford

http://www.w3.org/2001/XMLSchema#string

Vikki M Abrahams

http://www.w3.org/2001/XMLSchema#string

P304

3859-3868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-05-3948

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16585214

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor